In a report released today, Amit Dayal from H.C. Wainwright maintained a Buy rating on Aemetis (AMTX), with a price target of $28.00. The company’s shares closed last Thursday at $16.62.
According to TipRanks.com, Dayal is a top 25 analyst with an average return of 78.5% and a 57.5% success rate. Dayal covers the Industrial Goods sector, focusing on stocks such as Ballard Power Systems, Orion Energy Systems, and Ceco Environmental.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Aemetis with a $26.50 average price target, implying an 80.1% upside from current levels. In a report issued on March 8, Stifel Nicolaus also initiated coverage with a Buy rating on the stock with a $25.00 price target.
See today’s analyst top recommended stocks >>
Aemetis’ market cap is currently $265.3M and has a P/E ratio of -11.50. The company has a Price to Book ratio of -2.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Aemetis, Inc. operates as a renewable fuels and biochemicals company. The firm focuses on the acquisition, development, and commercialization of technologies that replace traditional petroleum-based products by the conversion of ethanol and biodiesel plants into biorefineries. It operates through the North America and India segments. The North America segment comprises of the Keyes Plant in California, the cellulosic ethanol facility in Riverbank, the cluster of biogas digesters on dairies near Keyes, the Goodland Plant, and the research and development facility in Minnesota. The India segment includes the Kakinada plant, administrative offices in Hyderabad, and holding companies in Nevada and Mauritius. Its products include glycerin, ethanol, food and feed, biodiesel, and edible oils. The company was founded by Eric Armstrong McAfee in 2005 and is headquartered in Cupertino, CA.
